The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 5 - 21 |
| Updated: | 10/26/2017 |
| Start Date: | August 2009 |
| End Date: | June 2010 |
Bowel preparation solutions containing Polyethylene Glycol is a commonly used preparation of
the colon for colonoscopy in children. However young children and adolescents often subject
to the volume and taste of liquid that must be consumed for an adequate preparation.
Currently almost all of our patients experience some difficulty with completing the colyte
preparation and approximately 10-20% is unable to achieve adequate cleansing due to inability
to drink the solution. The standard colyte solution is salty and often impedes children from
drinking the required amount of colyte preparation for adequate colon cleansing. Miralax has
been used at a dose of 1.5gm/kg/day to a maximum of 102 gms /day as four day prep Four day
bowel prep can be extremely frustrating for the parents and the patients. This may result in
low patient acceptance, limiting compliance leading to inadequate colonoscopy. Decreasing the
duration of the prep may increase the compliance and provide better colon visualization.
Hence a Cross sectional study looking at the safety,efficacy,tolerability of PEG 3350 mixed
in Gatorade G(TM) as a bowel prep in children needs to be conducted. Consent will be obtained
from parents and assent will be obtained from patients. Previous laboratory tests for each
patient will be reviewed. All patients in the study will be required to consume
MiralaxTM/Gatorade GTM the day prior to their procedure. The patients will be given written
instructions as to how to much solution to take and how to prepare and consume the solution.
The patient shall be maintained on a clear liquid diet the day prior to the procedure. Once
patients arrive for the colonoscopy they will be asked to complete a questionnaire regarding
their bowel preparation. Prior to the administration of IV fluids, 1ml of blood will be
obtained a basic metabolic panel. The patient will then undergo a colonoscopy by routine
procedure and technique. The endoscopist will complete a questionnaire when done with the
colonoscopy to rate the cleanliness of the colon.
We propose that MiralaxTM combined with Gatorade GTM given the day prior to colonoscopy is a
safe, tolerable and efficacious cleansing regimen for colonoscopy in children.
the colon for colonoscopy in children. However young children and adolescents often subject
to the volume and taste of liquid that must be consumed for an adequate preparation.
Currently almost all of our patients experience some difficulty with completing the colyte
preparation and approximately 10-20% is unable to achieve adequate cleansing due to inability
to drink the solution. The standard colyte solution is salty and often impedes children from
drinking the required amount of colyte preparation for adequate colon cleansing. Miralax has
been used at a dose of 1.5gm/kg/day to a maximum of 102 gms /day as four day prep Four day
bowel prep can be extremely frustrating for the parents and the patients. This may result in
low patient acceptance, limiting compliance leading to inadequate colonoscopy. Decreasing the
duration of the prep may increase the compliance and provide better colon visualization.
Hence a Cross sectional study looking at the safety,efficacy,tolerability of PEG 3350 mixed
in Gatorade G(TM) as a bowel prep in children needs to be conducted. Consent will be obtained
from parents and assent will be obtained from patients. Previous laboratory tests for each
patient will be reviewed. All patients in the study will be required to consume
MiralaxTM/Gatorade GTM the day prior to their procedure. The patients will be given written
instructions as to how to much solution to take and how to prepare and consume the solution.
The patient shall be maintained on a clear liquid diet the day prior to the procedure. Once
patients arrive for the colonoscopy they will be asked to complete a questionnaire regarding
their bowel preparation. Prior to the administration of IV fluids, 1ml of blood will be
obtained a basic metabolic panel. The patient will then undergo a colonoscopy by routine
procedure and technique. The endoscopist will complete a questionnaire when done with the
colonoscopy to rate the cleanliness of the colon.
We propose that MiralaxTM combined with Gatorade GTM given the day prior to colonoscopy is a
safe, tolerable and efficacious cleansing regimen for colonoscopy in children.
Inclusion Criteria:
1. Patients five years old or older that present to the pediatric GI clinic and are capable
of taking oral liquids and have been scheduled for a colonoscopy.
2. Patients who are able to communicate their discomfort and preferences.
Exclusion Criteria:
1. Patients that are neurologically compromised
2. Patients in need of emergent colonoscopy
3. Patients with known metabolic, endocrine, renal or cardiac conditions.
4. Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal
obstruction or swallowing difficulties.
5. Patients with known electrolyte abnormalities.
6. Patients who are allergic to PEG-3350.
7. Patients that are known to be pregnant.
8. Patients with known fructose intolerance.
9. Patient younger than five years old.
1. Patients five years old or older that present to the pediatric GI clinic and are capable
of taking oral liquids and have been scheduled for a colonoscopy.
2. Patients who are able to communicate their discomfort and preferences.
Exclusion Criteria:
1. Patients that are neurologically compromised
2. Patients in need of emergent colonoscopy
3. Patients with known metabolic, endocrine, renal or cardiac conditions.
4. Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal
obstruction or swallowing difficulties.
5. Patients with known electrolyte abnormalities.
6. Patients who are allergic to PEG-3350.
7. Patients that are known to be pregnant.
8. Patients with known fructose intolerance.
9. Patient younger than five years old.
Inclusion Criteria:
- Patients five years old or older that present to the pediatric GI clinic and are
capable of taking oral liquids and have been scheduled for a colonoscopy.
- Patients who are able to communicate their discomfort and preferences.
Exclusion Criteria:
- Patients that are neurologically compromised
- Patients in need of emergent colonoscopy
- Patients with known metabolic, endocrine, renal or cardiac conditions.
- Presence of pre-existing ostomy, short bowel syndrome, gastric retention, intestinal
obstruction or swallowing difficulties.
- Patients with known electrolyte abnormalities.
- Patients who are allergic to PEG-3350.
- Patients that are known to be pregnant.
- Patients with known fructose intolerance.
- Patient younger than five years old.
We found this trial at
1
site
Click here to add this to my saved trials
